{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:43:03Z","timestamp":1760550183178},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.cyto.2016.12.027","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T14:00:51Z","timestamp":1483797651000},"page":"140-144","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The role of Visfatin in atherosclerotic peripheral arterial obstructive disease"],"prefix":"10.1016","volume":"91","author":[{"given":"Matthaios G.","family":"Pitoulias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lemonia","family":"Skoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos G.","family":"Pitoulias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Chatzidimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolia","family":"Margariti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minas","family":"Arsenakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios A.","family":"Pitoulias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.12.027_b0005","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1002\/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L","article-title":"Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis","volume":"32","author":"Rongvaux","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2016.12.027_b0010","first-page":"946427","article-title":"Visfatin\/Nampt: an adipokine with cardiovascular impact","author":"Romacho","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cyto.2016.12.027_b0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.metabol.2006.12.001","article-title":"Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus","volume":"56","author":"Takebayashi","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.cyto.2016.12.027_b0020","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2265.2008.03248.x","article-title":"Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis","volume":"69","author":"Zhong","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cyto.2016.12.027_b0025","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bbamcr.2008.01.004","article-title":"Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappa B activation in endothelial cells","volume":"1783","author":"Kim","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cyto.2016.12.027_b0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2016.12.027_b0035","first-page":"270","article-title":"Hyperhomocysteinemia and hypercoagulable state in carotid plaque evolution. Novel risk factors or coincidental risk predictors?","volume":"26","author":"Pitoulias","year":"2007","journal-title":"Int. Angiol."},{"key":"10.1016\/j.cyto.2016.12.027_b0040","first-page":"181","article-title":"The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions","volume":"103","author":"Gerrity","year":"1981","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2016.12.027_b0045","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2016.12.027_b0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.cyto.2016.12.027_b0055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jvs.2008.02.068","article-title":"Reappraisal of velocity criteria for carotid bulb\/internal carotid artery stenosis utilizing high-resolution B-mode ultrasound validated with computed tomography angiography","volume":"48","author":"Shaalan","year":"2008","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.cyto.2016.12.027_b0060","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0030-1249059","article-title":"Effects of visfatin on proliferation and collagen synthesis in rat cardiac fibroblasts","volume":"42","author":"Yu","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cyto.2016.12.027_b0065","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.106.665893","article-title":"Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization","volume":"115","author":"Dahl","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2016.12.027_b0070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2265.2008.03453.x","article-title":"Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans","volume":"71","author":"Liu","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cyto.2016.12.027_b0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.peptides.2014.04.008","article-title":"Serum levels of novel adipokines in patients with acute ischemic stroke: potential contribution to diagnosis and prognosis","volume":"57","author":"Kadoglou","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.cyto.2016.12.027_b0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1210\/jc.2005-2391","article-title":"Visfatin: a true or false trail to type 2 diabetes mellitus","volume":"91","author":"Arner","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2016.12.027_b0085","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2527\/jas.2010-2799","article-title":"Visfatin regulates genes related to lipid metabolism in porcine adipocytes","volume":"88","author":"Yang","year":"2010","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.cyto.2016.12.027_b0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/138161209787185814","article-title":"Nicotinamidephosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases","volume":"15","author":"Imai","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cyto.2016.12.027_b0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1152\/ajpcell.00357.2009","article-title":"Nicotinamidephosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in a high glucose environment","volume":"298","author":"Borradaile","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.cyto.2016.12.027_b0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/0929867053363207","article-title":"Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies","volume":"12","author":"Pacher","year":"2005","journal-title":"Curr. Med. Chem."},{"issue":"18","key":"10.1016\/j.cyto.2016.12.027_b0105","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2174\/092986708785133004","article-title":"Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions","volume":"15","author":"Adeghate","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cyto.2016.12.027_b0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5603\/EP.2015.0016","article-title":"Visfatin concentrations in obese patients in relation to the presence of newly diagnosed glucose metabolism disorders","volume":"66","author":"Kami\u0144ska","year":"2015","journal-title":"Endokrynol. Pol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616306135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616306135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T03:25:49Z","timestamp":1536117949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616306135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":22,"alternative-id":["S1043466616306135"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.12.027","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of Visfatin in atherosclerotic peripheral arterial obstructive disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}